Thus, our HER2-targeted CAR-NK cells were able to significantly slow tumor progression in this highly aggressive model of HER2 ovarian cancer and prolonged the overall survival of treated mice (Fig. 2C). The gene discussed is ERBB2; the disease is neoplasm.